18 June 2026 (closed)
Jakarta Composite Index (6,172.34) -48.40 -0.78%
Below is a list with tagged columns and company profiles.
Latest Reports COVID-19 Immunization Program Indonesia
Those who have been following the international news should be aware that there are growing signs that the existing COVID-19 vaccines are not enough to combat the COVID-19 pandemic. In Singapore, vaccinated individuals now account for about 75 percent of the city state's COVID-19 infections.
After a whopping 16 straight months of contraction (on an annual basis), the latest retail sales data (released by Bank Indonesia) showed that retail sales in Indonesia jumped 15.6 percent year-on-year (y/y) in April 2021. That is a strong rebound!
Latest Columns COVID-19 Immunization Program Indonesia
Another interesting month – August 2021 – has passed. Several new findings were released around the world that further improve our understanding of the COVID-19 virus and vaccines, although many pieces of the puzzle(s) remain missing.
It feels as if the world is, again, at a turning point. While there is a wide range of data that indicate improving economic conditions (both in Indonesia and the world as a whole), there also emerged room for concern.
For more than a year now, small-scale studies from around the world suggest that a medicine called Ivermectin (which is actually used to treat various types of parasite infestations) is effective to combat COVID-19, both in a prophylactic (prevention) and therapeutic (treatment) setting.
Last month, we started to become a bit optimistic after reading reports that COVID-19 immunization programs were taking off, both in Indonesia (per 13 January 2021) and abroad. Moreover, it was reported that the Pfizer and Moderna vaccines have an efficacy rate of around 95 percent.
